102 related articles for article (PubMed ID: 25933179)
1. Letter from the editor.
Hum Vaccin Immunother; 2015; 11(4):807. PubMed ID: 25933179
[No Abstract] [Full Text] [Related]
2. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2013 Dec; 9(12):2497-8. PubMed ID: 24569384
[No Abstract] [Full Text] [Related]
3. Letter from the Editor.
Hum Vaccin Immunother; 2018 Apr; 14(4):801. PubMed ID: 29630455
[No Abstract] [Full Text] [Related]
4. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2014; 10(7):1771-2. PubMed ID: 25424780
[No Abstract] [Full Text] [Related]
5. Letter from the Editor.
Ellis R; Weiss A
Hum Vaccin Immunother; 2015; 11(12):2745. PubMed ID: 26697970
[No Abstract] [Full Text] [Related]
6. Letter from the editor.
Ellis RW; Riedmann EM
Hum Vaccin; 2011; 7 Suppl():2-3. PubMed ID: 21546793
[No Abstract] [Full Text] [Related]
7. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2013 Oct; 9(10):2033. PubMed ID: 24084476
[No Abstract] [Full Text] [Related]
8. Letter from the Editor.
Pedersen AE
Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):1. PubMed ID: 28071184
[No Abstract] [Full Text] [Related]
9. Letter from the editor.
Ellis RW; Riedmann EM
Hum Vaccin Immunother; 2012 Mar; 8(3):281. PubMed ID: 22418878
[No Abstract] [Full Text] [Related]
10. Letter from the editor.
Ellis R; Weiss A
Hum Vaccin Immunother; 2014; 10(10):2777-8. PubMed ID: 25483814
[No Abstract] [Full Text] [Related]
11. Letter from the editor.
Ellis R; Weiss A
Hum Vaccin Immunother; 2015; 11(2):303. PubMed ID: 25826191
[No Abstract] [Full Text] [Related]
12. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2014; 10(1):1-2. PubMed ID: 24832715
[No Abstract] [Full Text] [Related]
13. From the guest editor: introduction for immunotherapy of cancer.
Weber JS
Cancer J; 2010; 16(4):294. PubMed ID: 20693838
[No Abstract] [Full Text] [Related]
14. Letter from the editor.
Hum Vaccin Immunother; 2016 May; 12(5):1089. PubMed ID: 27216202
[No Abstract] [Full Text] [Related]
15. The hybrid cell vaccination approach to cancer immunotherapy.
Trefzer U; Herberth G; Sterry W; Walden P
Ernst Schering Res Found Workshop; 2000; (30):154-66. PubMed ID: 10943322
[No Abstract] [Full Text] [Related]
16. [Immunotherapy for hematological neoplasms].
Yasukawa M
Rinsho Ketsueki; 2012 Oct; 53(10):1759-67. PubMed ID: 23037749
[No Abstract] [Full Text] [Related]
17. Letter from the editor.
Hum Vaccin Immunother; 2016 Jul; 12(7):1649. PubMed ID: 27398831
[No Abstract] [Full Text] [Related]
18. [Immunotherapy, vaccination].
Nishiki K; Yasuda T; Shiozaki H
Nihon Rinsho; 2011 Aug; 69 Suppl 6():392-8. PubMed ID: 22471050
[No Abstract] [Full Text] [Related]
19. Antitumor antibodies for immunotherapy of ovarian carcinomas.
Wagner U
Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125
[No Abstract] [Full Text] [Related]
20. Immunotherapy and vaccination after transplant: the present, the future.
Emery VC; Einsele H; Atabani S; Haque T
Infect Dis Clin North Am; 2010 Jun; 24(2):515-29. PubMed ID: 20466281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
